This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
ENTPD7 Polyclonal Antibody
catalog :
PA5-97710
quantity :
100 ug
price :
US 464.00
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot, ELISA, immunocytochemistry
product information
Product Type :
Antibody
Product Name :
ENTPD7 Polyclonal Antibody
Catalog # :
PA5-97710
Quantity :
100 ug
Price :
US 464.00
Clonality :
Polyclonal
Purity :
Protein G
Host :
Rabbit
Reactivity :
Human, Mouse
Applications :
ELISA: Assay-Dependent, Immunocytochemistry: 1:50-1:200, Western Blot: 1:2,000-1:10,000
Species :
Human, Mouse
Isotype :
IgG
Storage :
-20 C or -80 C if preferred
Description :
ENTPD7 is a multi-pass membrane protein. It belongs to the GDA1/CD39 NTPase family. It preferentially hydrolyzes nucleoside 5'-triphosphates. The order of activity with respect to possible substrates is UTP > GTP > CTP.
Immunogen :
Recombinant Human Ectonucleoside triphosphate diphosphohydrolase 7 protein (51-350AA)
Format :
Liquid
Applications w/Dilutions :
ELISA: Assay-Dependent, Immunocytochemistry: 1:50-1:200, Western Blot: 1:2,000-1:10,000
Aliases :
1810012B13Rik; 1810020C02Rik; 2810003F23Rik; ectonucleoside triphosphate diphosphohydrolase 7; ENTPD7; Kiaa4066; Lalp1; Lysal2; lysosomal apyrase-like 2; lysosomal apyrase-like protein 1; NTPDase 7; RP11-483F11.1
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments